The function of activating KIRs remains an open question, but specific KIR activating genes, such as KIR3DS1, have been associated with less GvHD in allogeneic HSCT [92], whereas others, such as KIR2DS1, protect from leukemia relapse [93,94]. Here, KIR3DL1 is linked to leukemia.